INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OPTIC NERVE DISEASES AND MITOCHONDRIAL DYSFUNCTION DISEASES, COMPRISING EXOSOMES ISOLATED FROM HUMAN PLACENTA-DERIVED MESENCHYMAL STEM CELLS"

GENEVA, March 10 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566) filed a patent application (PCT/KR2024/013105) for "PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OPTIC NERVE DISEASES AND MITOCHONDRIAL DYSFUNCTION DISEASES, COMPRISING EXOSOMES ISOLATED FROM HUMAN PLACENTA-DERIVED MESENCHYMAL STEM CELLS" on Sep 02, 2024. With publication no. WO/2025/048567, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) syst...